The Ophthalmic Drugs Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of ophthalmic drugs has seen significant growth recently. The market will expand from $39.36 billion in 2024 to $42.65 billion in 2025, with a compound annual growth rate (CAGR) of 8.3%.
The Ophthalmic Drugs Global Market Report 2025 projects that by 2029, the market size for ophthalmic drugs will reach $57.4 billion, growing at a compound annual growth rate (CAGR) of 7.7%.
Download Your Free Sample of the 2025 Ophthalmic Drugs Market Report and Uncover Key Trends Now!The key drivers in the ophthalmic drugs market are:
• Biopharmaceutical innovations
• Increasing prevalence of myopia
• Growth of the aging population
• Implementation of personalized medicine approaches
The ophthalmic drugs market covered in this report is segmented –
1) By Type: Prescription Drugs, Over-The-Counter Drugs
2) By Class: Anti-Allergy, Anti-Inflammatory, Anti-Glaucoma, Other Classes
3) By Disease: Dry Eye, Eye Allergy, Glaucoma, Eye Infection, Retinal Disorders, Uveitis, Other Diseases
4) By Dosage Form: Liquid Ophthalmic Drug Forms, Solid Ophthalmic Drug Forms, Semisolid Ophthalmic Drug Forms, Multicompartment Drug Delivery Systems
5) By Distribution Channel: Hospital Pharmacies, Drug Stores, Online Pharmacies
The key trends in the ophthalmic drugs market are:
• Biologics and gene therapies are emerging as significant trends in the market.
• There is a growing focus on therapeutic solutions for dry eye conditions.
• Advancements in treatment procedures for glaucoma are increasingly shaping the market.
• The market is witnessing a shift towards combination therapies and treatments aimed at age-related macular degeneration (AMD).
The major players in the ophthalmic drugs market are:
• AbbVie Inc
North America was the largest region in the ophthalmic drugs market in 2024